Hercules Capital, Inc. (HCXY) is a leading publicly traded business development company that specializes in offering tailored financing solutions to growth-oriented enterprises, with a focus on the life sciences and technology sectors. Leveraging its deep industry expertise and strategic partnerships, Hercules delivers bespoke debt and equity financing that drives innovation and value creation. The company prioritizes capital preservation while striving to generate risk-adjusted returns, making it a compelling opportunity for institutional investors looking to gain diversified exposure to high-growth industries. Hercules's robust investment strategy is adept at identifying and supporting promising firms within a competitive market landscape, enhancing its appeal as a financial partner.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $190.88M |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding